STX · Verdict

A summary of rules, not a profit forecast — don’t buy just because of a green verdict.

• ▼ P/E 33.8 — expensive for this stock (over 9 y: from 6.7 to 69.4)
• ▼ P/E 33.8 vs peer median 24.7 — more expensive than peers
• ▼ P/S 10.7 — expensive for this stock (over 10 y: from 1.1 to 18.1)
• ▼ P/S 10.7 vs peer median 9.5 — more expensive than peers
• ▼ EV/EBITDA 25.5 — expensive for this stock (over 9 y: from 7.6 to 52.9)
• ▼ EV/EBITDA 25.5 vs peer median 21.6 — more expensive than peers
• ▼ FCF yield 2.1% — expensive for this stock (over 10 y: from 1.4% to 12.8%)
• ▼ FCF yield 2.1% vs peer median 2.0% — more expensive than peers
• ▼ Cyclical company at peak earnings: P/E 33.8 is understated; on average earnings over 10 y it is 129.2
• ▲ Forward P/E 9.9 is below the current one — earnings growth expected

• ▼ Share count up 11% in 3 y — your stake is being diluted
• ▲ Piotroski 8/9 — strong financial health
• ▲ ROE 259% — high return on equity
• ▲ Net margin rose: -7.2% → 26.1%
• ▲ Free cash flow positive every year

• ▲ Earnings per share grows 21.0% per year (5 y)
• ▲ Analysts raised the earnings forecast by +12.4% in 90 days

• ▼ Over 6 mo weaker than its sector (XLK) by 17%
• ▼ Price below SMA200 — long-term downtrend
• ▲ SMA50 above SMA200 — trend up
• ▲ Over a year +140% vs S&P 500 +11% — stronger than the market

• ▼ Risk/reward 1:0.9 — the target is closer than the stop
• ▼ Volatility 74% per year — much higher than the market (13%)
• ▼ Max drawdown in the period -58% — deep
• ▼ Beta 2.08 — moves more than the market

• ▲ Consensus of 24 analysts — buy
• ▲ Mean analyst target +60% from the current price
• ▲ Insiders buying over 6 mo

• ▲ S&P 500 above SMA200 — the market is in an uptrend
• ▲ Sector (XLK) above SMA200 — in an uptrend